Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC6H13KN3S2 |
InChIKeyURQBSYILFUXTIU-UHFFFAOYSA-N |
CAS Registry1358567-64-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Drug-Resistant Tuberculosis | Preclinical | FI | 27 Dec 2023 |